Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

Multiple Assemblies exist for SMTL entry 6ugu
Crystal structure of the Fab fragment of anti-TNFa antibody infliximab (Remicade) in a C-centered orthorhombic crystal form, Lot C; X-RAY DIFFRACTION 2.20 Å

SMTL ID
6ugu.1
Ligands
-
Polypeptides
PF06438179 Fab Heavy Chain; PF06438179 Fab Light Chain
Oligo-state
hetero-1-1-mer
SMTL ID
6ugu.2
Ligands
-
Polypeptides
PF06438179 Fab Heavy Chain; PF06438179 Fab Light Chain
Oligo-state
hetero-1-1-mer